Download Word format - Ipswich and East Suffolk CCG

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Adherence (medicine) wikipedia , lookup

Bilastine wikipedia , lookup

Transcript
Perceptions of healthcare professionals (HCPs) in primary care to stepping
down treatment in people with asthma aged 12+ years
Background
1.
Please identify your role in
primary care
GP
□
Nurse Practitioner □
PN
□
Healthcare Assistant □
Other □, please specify....
Yes □
2.
Do you see people with asthma?
Locum □
No □
If No, thank you very much for your time you do not need to complete the
questionnaire.
Review of people with asthma
3.
How many people with asthma do
you usually see in one month?
4.
When did you last look at the
BTS/SIGN guidelines for the
management of asthma?
5.
Do you adjust patients’ asthma
medication?
11-20 □
21-30
31-40 □
41-50 □
>50 □
Last week □
Last year □
Last month □
Last 6 months □
1-10
□
Yes □
6.
How confident do you feel about
stepping down asthma
medication?
Do you have a practice or locality
formulary for managing asthma?
No □
If No, who in your team adjusts patients asthma medication? .....................
1
Not very confident
Yes □
7.
□
2
3
4
5
Very confident
No □
If Yes, does it list:
Specific drugs
Drugs by class
Doses of drug
Device choice
Yes
Yes
Yes
Yes
□
□
□
□
No
No
No
No
□
□
□
□
Does this have guidance about stepping down treatment?
Yes □
No □
8.
Thinking about people 12+ with
asthma you have seen in previous
3 months, please indicate if you
use the following to assess asthma
control:
RCP 3 questions
Yes □
No □
Asthma Control Test (ACT)
Yes □
No □
Checking Peak Expiratory Flow Rate
(PEFR)
Reliever usage
(by asking patient and/or checking
number of inhalers prescribed)
Yes □
No □
Yes □
No □
1|Page
Napp Pharmaceuticals Ltd have supported this research through the production and formatting of the
questionnaire. The content was produced by Deirdre Siddaway.
RCP – have you had difficulty sleeping because of your asthma symptoms
(including cough)?
No symptoms for previous >3 months
No symptoms for previous 1-3 months
No symptoms for previous 1 month
□
□
□
RCP –have you had your usual asthma symptoms during the day?
9.
For the assessments you answered
yes to in question 8, what level of
symptoms would prompt you to
step down treatment?
No symptoms for previous >3 months
No symptoms for previous 1-3 months
No symptoms for previous 1 month
□
□
□
RCP – Has your asthma interfered with your usual activities?
No symptoms for previous >3 months
No symptoms for previous 1-3 months
No symptoms for previous 1 month
□
□
□
25 □
□
ACT:
20-24 □
<20
>90% □ >80% □ 70-80%
PEFR (%best/predicted):
Reliever usage in the last 3 months:
None in last 3 months □
Used <3 in last 3 months □
10. Once controlled, how long do you
wait until you step down
treatment?
11. When you step down asthma
treatment would you reduce the
dose of patients medication by:
3 months □
6 months □
1 year
Changing to a lower dose of
inhaled cortico-steroid inhaler
Changing to a lower dose of
long-acting beta2 agonist inhaler
Reducing the number of
puffs/actuations of current
inhaler
Other, please specify...
□
□
Used <5
□
□ Would not follow-up
□
>1 year
□
Yes □
No □
Yes □
No □
Yes □
No □
12. Thinking about patients whose
treatment you have stepped
down, please list any challenges
you had stepping down treatment
e.g. time
13. When would you arrange to
follow-up with the patient after
stepping down treatment?
14. What advice would you give about
stepping up treatment if patients
experience symptoms?
4-6 weeks □
2 months □
3 months
Make an appointment to see HCP
Increase the actuations taken
Other, please specify....
Yes □
Yes □
No □
No □
Any other comments:
Thank you very much for completing this questionnaire. Please return to: Deirdre Siddaway, The Chesterfield Drive
Practice, 29 Chesterfield Drive, Ipswich, IP1 6DW or email to: [email protected]
2|Page
Napp Pharmaceuticals Ltd have supported this research through the production and formatting of the
questionnaire. The content was produced by Deirdre Siddaway.